研究概要
这些结果表明,通过工程化改造细胞间界面的物理特性,可以主动调节免疫突触的效率。
中文摘要
细胞间连接和界面稳定性对细胞激活具有关键影响,尤其是在实体瘤中,物理限制阻碍了效应细胞与靶细胞的持续接触。特别是,NK 细胞中有效的免疫突触形成需要稳定的细胞间接触。然而,大多数现有策略依赖于肿瘤抗原介导的识别,因此易受抗原异质性和免疫逃逸的影响。在此,我们开发了一种基于两亲性单链DNA(ssDNA)的表面工程策略,能够实现可控且不依赖受体的细胞间界面调控。脂质偶联的ssDNA构建体被设计为:(a) 锚定在细胞膜上,(b) 通过DNA杂交诱导序列特异性结合,(c) 实现连接细胞对的热可逆解离。这种膜修饰可快速实现,互补ssDNA配对显著增加了效应细胞-靶细胞连接、细胞毒性颗粒和细胞因子分泌,以及三阴性乳腺癌细胞的清除。重要的是,该平台在3维肿瘤球模型中仍然有效,其中两亲性ssDNA实现了稳健的膜定位,并促进了NK 细胞介导的肿瘤破坏。总体而言,这些结果表明,免疫突触效率可以通过工程化细胞间界面的物理特性来主动调控。此外,这种基于可编程ssDNA的平台为调控多种细胞-细胞界面提供了一个多功能框架,在免疫治疗、组织工程和基于细胞的治疗系统中具有广泛适用性。
展开英文摘要原文
Intercellular tethering and interface stability critically influence cellular activation, particularly in solid tumors where physical constraints limit sustained effector-target engagement. In particular, effective immune-synapse formation in natural killer cells requires stable cell-cell contact. However, most existing strategies rely on tumor-antigen-mediated recognition and are therefore vulnerable to antigen heterogeneity and immune escape. Here, we developed an amphiphilic single-stranded DNA (ssDNA)-based surface-engineering strategy that enables controllable and receptor-independent regulation of intercellular interfaces. Lipid-conjugated ssDNA constructs were designed to (a) anchor onto cell membranes, (b) induce sequence-specific association through DNA hybridization, and (c) enable thermally reversible dissociation of tethered cell pairs. This membrane modification was rapidly achieved, and complementary ssDNA pairing markedly increased effector-target tethering, cytotoxic granule and cytokine secretion, and elimination of triple-negative breast cancer cells. Importantly, this platform remained effective in 3-dimensional tumoroid models, where amphiphilic ssDNA enabled robust membrane localization and facilitated natural-killer-cell-mediated tumor disruption. Collectively, these results demonstrate that immune-synapse efficiency could be actively modulated by engineering the physical properties of intercellular interfaces. Moreover, this programmable ssDNA-based platform offers a versatile framework for regulating diverse cell-cell interfaces, with broad applicability across immunotherapy, tissue engineering, and cell-based therapeutic systems.
论文信息
- 作者
- Kim S、Lee CE、Jangid AK、Kim K
- 第一作者单位
- Immuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.South Korea
- 通讯作者单位
- Department of Chemical and Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea.South Korea
- 期刊
- Biomaterials research2026